Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2022 |
Aug. 31, 2021 |
Aug. 31, 2022 |
Aug. 31, 2021 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue | $ 135,428 | $ 0 | $ 135,428 | $ 0 |
| Expenses : | ||||
| Research and development (Note 14) | 3,751,155 | 5,284,797 | 10,551,639 | 13,922,632 |
| General and administrative (Notes 15) | 4,010,687 | 3,116,226 | 15,047,328 | 6,276,797 |
| Depreciation and amortization (Notes 7 and 8) | 138,100 | 140,770 | 276,642 | 272,770 |
| Interest and other financial expenses (Note 19) | 43,230 | 33,102 | 84,559 | 63,689 |
| Interest income | (9,334) | (8,413) | (22,527) | (18,174) |
| Foreign exchange loss (gain) | (93,244) | (174,066) | (91,108) | 32,066 |
| Total expenses | 7,840,594 | 8,392,416 | 25,846,535 | 20,549,780 |
| Net loss | (7,705,166) | (8,392,416) | (25,711,105) | (20,549,780) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | (412,504) | (353,713) | (417,270) | (146,898) |
| Comprehensive income (loss) | $ (8,117,670) | $ (8,746,129) | $ (26,128,375) | $ (20,696,678) |
| Loss per share Basic and diluted | $ (0.16) | $ (0.19) | $ (0.54) | $ (0.47) |
| Weighted average common shares outstanding Basic and diluted | 47,400,709 | 44,132,872 | 47,400,640 | 43,282,989 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|